All lobbying filings

RED+BLUE STRATEGIES

RED+BLUE STRATEGIES filed a Q3 report for DAVITA INC. on October 20, 2026, reporting $70,000 in lobbying income.

Lobbying for DAVITA INC. · A leading provider of dialysis services in the United States.

All filings by RED+BLUE STRATEGIES · Everything DAVITA INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.

Bills named in this filing 2

H.R. 2199
Restore Protections for Dialysis Patients Act
S. 1173
Restore Protections for Dialysis Patients Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.